Creo Medical Group says Speedboat RS2 device used by a second gastroenterologist
Creo Medical Group said Wednesday that its multi-modality endoscopic device, Speedboat RS2, has been used by a second gastroenterologist at a second NHS site to treat patients.
Craig Gulliford, chief executive officer of Creo Medical, commented: "We are excited by today's announcement as it provides further validation of our technology. It is incredible that these patients were conscious, talking to the endoscopist and able to watch the procedure live on screen. While we need to collect additional supportive clinical data, we are encouraged by the results we've seen to date. We believe that procedures like this have the potential to eliminate the need for subsequent bowel surgery, with the obvious patient benefits aligned with material advantages to the healthcare system in terms of cost and patient safety."